Safety of Tdap vaccine in pregnant women: an observational study

Pregnancy Outcomes After Antepartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination

(2015) Jamie L. Morgan et al.   OBSTETRICS AND GYNECOLOGY

Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy

(2015) Lakshmi Sukumaran et al.   OBSTETRICS AND GYNECOLOGY

Maternal immunization – Promises and concerns

(2015) Janet A. Englund   VACCINE

Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System

(2015) Hema Datwani et al.   VACCINE

Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents

(2015) Helen Petousis-Harris et al.   Human Vaccines & Immunotherapeutics

The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States

(2015) Pedro L Moro et al.   Human Vaccines & Immunotherapeutics

A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013

(2014) G. Dabrera et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes

(2014) Elyse O. Kharbanda et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants

(2014) Flor M. Munoz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effectiveness of maternal pertussis vaccination in England: an observational study

(2014) Gayatri Amirthalingam et al.   LANCET

Safety of pertussis vaccination in pregnant women in UK: observational study

(2014) K. Donegan et al.   BMJ-British Medical Journal

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

(2012) Yenlik A. Zheteyeva et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

(2012) Paul L. McCormack   DRUGS

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance

(2012) Helen Petousis-Harris et al.   VACCINE

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

(2010) Jussi Mertsola et al.   CLINICAL INFECTIOUS DISEASES

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

(2010) Robert Booy et al.   VACCINE

A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

(2008) Jane Gidudu et al.   VACCINE

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age

(2008) Mark Blatter et al.   VACCINE